Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Erik Nygaard
Title
Product Development Director, BWXT Advanced Technologies LLC
Bio
Erik T. Nygaard is director, Research and Engineering (R&E) for BWXT Advanced Technologies LLC, a subsidiary of BWX Technologies, Inc. (BWXT). In his current role, Mr. Nygaard oversees R&E which includes medical isotopes, advanced nuclear reactors, data science and additive manufacturing. He most recently served as the director, Isotope Research & Development focusing on the company’s groundbreaking medical isotope technology announced in early 2018 and has initiated two additional development programs for therapeutic radioisotope production.
During his tenure at BWXT, Mr. Nygaard has held several engineering positions of increasing responsibility. He served as the product line manager responsible for developing isotope technology, a nuclear engineer in the company’s Advanced Reactors and Engineering group, and a safety analysis engineer and test engineer for mPowerTM Reactor, the company’s Generation III++ small modular reactor project.
Mr. Nygaard joined the company in 2010 as the acting chief reactor engineer for the Medical Isotope Production System program while still a student at the University of Wisconsin-Madison. He was also licensed by the Nuclear Reactor Commission to operate the university’s nuclear reactor. Most recently, he became Nuclear Quality Assurance certified by the American Society of Mechanical Engineers.
Mr. Nygaard earned a bachelor’s and master’s degree in nuclear engineering from the University of Wisconsin – Madison and holds two U.S. patents, with two patents pending. He is also a member of the American Nuclear Society.
During his tenure at BWXT, Mr. Nygaard has held several engineering positions of increasing responsibility. He served as the product line manager responsible for developing isotope technology, a nuclear engineer in the company’s Advanced Reactors and Engineering group, and a safety analysis engineer and test engineer for mPowerTM Reactor, the company’s Generation III++ small modular reactor project.
Mr. Nygaard joined the company in 2010 as the acting chief reactor engineer for the Medical Isotope Production System program while still a student at the University of Wisconsin-Madison. He was also licensed by the Nuclear Reactor Commission to operate the university’s nuclear reactor. Most recently, he became Nuclear Quality Assurance certified by the American Society of Mechanical Engineers.
Mr. Nygaard earned a bachelor’s and master’s degree in nuclear engineering from the University of Wisconsin – Madison and holds two U.S. patents, with two patents pending. He is also a member of the American Nuclear Society.
